Strainsforpains Inc (PK:EBYH)
Business Focus: Software
Mar 14, 2024 08:00 am ET
Strainsforpains CEO Simon Shainberg Discusses Entering 191 Billion Dollar Anti-Inflammatory Market, and Strategic Partnership and Research Potential with GenBio Corp.
Strainsforpains, Inc. (OTC PINK:EBYH) Strainsforpains, Inc. has entered into a strategic partnership with GenBio to license potentially new anti-inflammatory compounds to be included in Strainsforpains CBD branded products. Strainsforpains...
Mar 07, 2024 08:00 am ET
Strainsforpains, Inc. Investors Update: Strainsforpains, Inc. Showing Strong Revenue Growth
-- (E-Buy Homes, Inc. DBA/Strainsforpains, Inc.) (OTC Markets: EBYH) Strainsforpains, Inc. is pleased to announce the successful acquisition of a substantial $130,000 distribution order from Exploration Solutions, LLC, (ESLLC) a Brooklyn, NY based...
Feb 29, 2024 09:00 am ET
StrainsForPains, Inc. Discusses Inspiration, App Technology and CBD Market Entrance with The Stock Day Podcast
Phoenix, Arizona--(Newsfile Corp. - February 29, 2024) - The Stock Day Podcast welcomed StrainsForPains, Inc. (OTC Pink: EBYH) ("the Company"), a medical marijuana recommendation engine that guides patients to the appropriate cannabinoid levels, medical cannabis strains, and consumption methods for their specific ailment. CEO of the Company, Simon Shainberg, joined Stock Day host Matthew Dunehoo.
Feb 23, 2024 09:00 am ET
Strainsforpains Inc. Announces Corporate Update
(Strainsforpains, Inc.) (OTC Markets: EBYH). Strainsforpains is pleased to announce that it has increased the capacity of its Pennsylvania facility to accommodate the company’s growing CBD product line. In the 4th quarter of 2023, the company...
Jan 19, 2024 09:00 am ET
Strainsforpains, Inc. secures its largest orders to date from NYC establishments
Strainsforpains, Inc. Announces Corporate Update (Strainsforpains, Inc.) (OTC Markets: EBYH). Strainsforpains, Inc. is pleased to announce it has closed out 2023 with its largest orders to date, valued at $65,000, from various CBD and health...
Aug 11, 2021 01:45 pm ET
Strainsforpains, Inc. Enters into a Letter of Intent to Acquire Cannasphere Biotech, LLC and Commences Good Faith Negotiations and Pre-Purchase Due Diligence
NEW YORK, NY / ACCESSWIRE / August 11, 2021 / Strainsforpains, Inc. (OTC Markets:EBYH), a New York-based purveyor of enterprise-class technology solutions for the cannabis industry, announces that it has signeda letter of intent to acquire Cannasphere Biotech, LLC, an Arizona-based developer and manufacturer of water-soluble, nanoliposomal cannabinoid products serving business clients in the cannabis industry.Poised to emerge as a global player in the rapidly-growing cannabis and CBD markets, Strainsforpains is well-positioned with its
Jan 17, 2019 04:26 pm ET
Strainsforpains, Inc. Provides Corporate Update
via NEWMEDIAWIRE -- Strainsforpains, Inc. (OTC Pink:EBYH) is pleased to announce a shareholder update. As our focus since 2016 has been cannabis technology, we have developed an APP that will revolutionize the medical cannabis technology industry....
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Canadianinsider.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Read more...Insider information is based on filings made on the System
for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission.Read less
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Interactive technical study charts by TradingView. Copyright © 2024 INK Research Corp. All rights reserved. All trade-marks or trade names not owned by INK Research Corp. are the property of their respective owners.